Cardiotoxicity is a genuine antagonistic impact of numerous ordinary chemotherapy specialists. There are various sorts of cardiotoxicity, including reversible, irreversible, intense, constant, and late-beginning. Information on the impacts of cardiotoxicity, its administration, and dose alterations for chemotherapeutic specialists, for example, anthracyclines, fluorouracil, taxanes, monoclonal antibodies, and tyrosine kinase inhibitors is essential for the early identification of cardiotoxicity. It is significant for drug specialists to know about these cardiotoxic impacts so as to make fitting proposals for measurements changes and observing of long haul impacts.